Patents by Inventor Jorge Salas Solana

Jorge Salas Solana has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230026909
    Abstract: The invention relates to compounds of Formula (I) as described herein, useful as histone deacetylase 6 (HDAC6) inhibitors. The invention also relates to pharmaceutical compositions comprising these compounds and to their use in therapy.
    Type: Application
    Filed: February 10, 2022
    Publication date: January 26, 2023
    Inventors: Elena CARCELLER GONZÁLEZ, Alberto ORTEGA MUÑOZ, Jorge SALAS SOLANA
  • Publication number: 20220298156
    Abstract: The invention relates to compounds as described herein, useful as histone deacetylase 6 (HDAC6) inhibitors. The invention also relates to pharmaceutical compositions comprising these compounds and to their use in therapy.
    Type: Application
    Filed: June 5, 2020
    Publication date: September 22, 2022
    Inventors: Elena CARCELLER GONZÁLEZ, Alberto ORTEGA MUÑOZ, Jorge SALAS SOLANA
  • Publication number: 20200339569
    Abstract: The invention relates to compounds of Formula (I) as described herein, useful as histone deacetylase 6 (HDAC6) inhibitors. The invention also relates to pharmaceutical compositions comprising these compounds and to their use in therapy.
    Type: Application
    Filed: December 5, 2018
    Publication date: October 29, 2020
    Inventors: Elena CARCELLER GONZÁLEZ, Alberto ORTEGA MUÑOZ, Jorge SALAS SOLANA
  • Patent number: 8946257
    Abstract: N-containing heteroaryl derivatives of formula I or II, wherein the meanings for the various substituents are as disclosed in the description. These compounds are useful as JAK, particularly JAK3, kinase inhibitors.
    Type: Grant
    Filed: June 28, 2013
    Date of Patent: February 3, 2015
    Assignee: Vectura Limited
    Inventor: Jorge Salas Solana
  • Publication number: 20130289015
    Abstract: N-containing heteroaryl derivatives of formula I or II, wherein the meanings for the various substituents are as disclosed in the description. These compounds are useful as JAK, particularly JAK3, kinase inhibitors.
    Type: Application
    Filed: June 28, 2013
    Publication date: October 31, 2013
    Inventors: Carmen Almansa Rosales, Jorge Salas Solana, Robert Soliva Soliva, Sergio Rodriguez Escrich, Maria Cristina Sicre Gonzalez
  • Patent number: 8501735
    Abstract: N-containing heteroaryl derivatives of formula I or II, wherein the meanings for the various substituents are as disclosed in the description. These compounds are useful as JAK, particularly JAK3, kinase inhibitors.
    Type: Grant
    Filed: October 29, 2010
    Date of Patent: August 6, 2013
    Assignee: Palau Pharma, S.A.
    Inventors: Carmen Almansa Rosales, Jorge Salas Solana, Robert Soliva Soliva, Sergio Rodriguez Escrich, Maria Cristina Sicre González
  • Publication number: 20130131038
    Abstract: N-containing heteroaryl derivatives of formula I or II, wherein the meanings for the various substituents are as disclosed in the description. These compounds are useful as JAK, particularly JAK3, kinase inhibitors.
    Type: Application
    Filed: October 29, 2010
    Publication date: May 23, 2013
    Inventors: Carmen Almansa Rosales, Jorge Salas Solana, Robert Soliva Soliva, Sergio Rodríguez Escrich, Maria Cristina Sicre Gonzåles
  • Publication number: 20120245140
    Abstract: N-containing heteroaryl derivatives of formula I or II, wherein the meanings for the various substituents are as disclosed in the description. These compounds are useful as JAK, particularly JAK3, kinase inhibitors.
    Type: Application
    Filed: October 29, 2010
    Publication date: September 27, 2012
    Inventors: Carmen Almansa Rosales, Jorge Salas Solana, Robert Soliva Soliva, Sergio Rodríguez Escrich, Maria Cristina Sicre Gonzåles
  • Publication number: 20110160185
    Abstract: Pyrrolopyrimidine derivatives of Formula (I) that are useful as JAK3 kinase inhibitors.
    Type: Application
    Filed: March 31, 2008
    Publication date: June 30, 2011
    Inventors: Jorge Salas Solana, Carmen Almansa Rosales, Robert Soliva Soliva, Montserrat Fontes Ustrell, Marc Vendrell Escobar
  • Publication number: 20100204187
    Abstract: Purine derivatives of Formula (I), wherein the meanings for the various substituents are as disclosed in the description. These compounds are useful as JAK3 kinase inhibitors.
    Type: Application
    Filed: January 23, 2008
    Publication date: August 12, 2010
    Inventors: Jorge Salas Solana, Carmen Almansa Rosales, Robert Soliva Soliva, Montserrat Fontes Ustrell, Marina Virgili Bernadó, Josep Comelles Espuga, José Javier Pastor Porras
  • Publication number: 20100113420
    Abstract: Pyrrolopyrimidine derivatives of Formula (I) that are useful as JAK3 kinase inhibitors.
    Type: Application
    Filed: March 31, 2008
    Publication date: May 6, 2010
    Inventors: Jorge Salas Solana, Carmen Almansa Rosales, Robert Soliva Soliva, Montserrat Fontes Ustrell, Marc Vendrell Escobar
  • Publication number: 20090306038
    Abstract: 2-Aminopyrimidine derivatives of formula (I) that are useful as modulators of the H4 receptor.
    Type: Application
    Filed: September 12, 2006
    Publication date: December 10, 2009
    Inventors: Elena Carceller González, Jorge Salas Solana, Robert Soliva Soliva, Eva Maria Medina Fuentes, Josep Marti Via
  • Publication number: 20050143391
    Abstract: The present invention relates to new compounds of Formula (I) and the salts, solvates and prodrugs thereof, wherein the meanings for the various substituents are as disclosed in the description. These compounds are useful as integrin ?4 antagonists.
    Type: Application
    Filed: April 8, 2003
    Publication date: June 30, 2005
    Applicant: J. Uriach Y Compañia S.A.
    Inventors: Elena Carceller Gonzalez, Jorge Salas Solana, Cristina Alvarez Farrerons, Juan Andreu Azanza
  • Patent number: 6809087
    Abstract: The present invention relates to the sodium salt of (Z)-2-hydroxy-5-([4-[3-[4-[(2-methyl-1H-imidazo[4,5-c]pyridin-1-yl)methyl ]-1-piperidinyl]-3-oxo-1-phenyl-1-propenyl]phenyl]azo]benzoic acid, as well as to the pharmaceutical compositions containing it, to a procedure for its preparation and to its use for the manufacture of medicaments for the treatment or prevention of inflammatory bowel disease.
    Type: Grant
    Filed: May 6, 2003
    Date of Patent: October 26, 2004
    Assignee: J. Uriach & Cia. S.A.
    Inventors: Elena Carceller, Jorge Salas Solana, José Ignacio Escamilla, Joaquim Ramis, Javier Forn
  • Publication number: 20030176401
    Abstract: The present invention relates to the sodium salt of (Z)-2-hydroxy-5-[[4-[3-[4-[(2-methyl-1H-imidazo[4,5-c]pyridin-1-yl)methyl]-1-piperidinyl]-3-oxo-1-phenyl-1-propenyl]phenyl]azo]benzoic acid, as well as to the pharmaceutical compositions containing it, to a procedure for its preparation and to its use. for the manufacture of medicaments for the treatment or prevention of inflammatory bowel disease.
    Type: Application
    Filed: May 6, 2003
    Publication date: September 18, 2003
    Inventors: Elena Carceller, Jorge Salas Solana, Jose Ignacio Escamilla, Joaquim Ramis, Javier Forn